Wed26 Opening plenary: Transforming diabetes care: National perspective on hybrid closed loop implementation and equity 09:20 am10:40 am Hall 5 Chair:Clare Hambling, Norfolk Fulya Mehta, Liverpool Dita Aswani, Sheffield Charlotte Boughton, Cambridge Brian Kennon, Scotland Partha Kar, Portsmouth Colette Marshall, Diabetes UK Jenni Minto, Scottish Government Opening words 9:00 am9:10 am Colette Marshall, Diabetes UK Welcome address 9:10 am9:20 am Jenni Minto, Scottish Government Opening comments 9:20 am9:25 am Clare Hambling, Norfolk Fulya Mehta, Liverpool Interim GIRFT report for children and young people's services: Technology challenges and wins 9:25 am9:45 am Dita Aswani, Sheffield Pumps and hybrid closed loop in type 2 diabetes: The research 9:45 am10:00 am Charlotte Boughton, Cambridge Equity in action: Scotland's journey to universal hybrid closed loop access 10:00 am10:20 am Brian Kennon, Scotland From disparities to access: Diabetes technology to boldly go 10:20 am10:40 am Partha Kar, Portsmouth
Interim GIRFT report for children and young people's services: Technology challenges and wins 9:25 am9:45 am Dita Aswani, Sheffield
Pumps and hybrid closed loop in type 2 diabetes: The research 9:45 am10:00 am Charlotte Boughton, Cambridge
Equity in action: Scotland's journey to universal hybrid closed loop access 10:00 am10:20 am Brian Kennon, Scotland
Wed26 Banting Memorial Lecture 10:40 am11:20 am Hall 5 Chair:Kamlesh Khunti, Leicester Jonathan Valabhji, London Aligning clinical practice, policy and research 10:40 am11:20 am Jonathan Valabhji, London
Wed26 Leading self: Leadership in complex healthcare environments 10:40 am11:20 am Dochart Chair:Sarah Alicea, London
Wed26 Preparing the UK for early detection and treatment of type 1 diabetes 11:50 am01:10 pm Lomond Chair:Rachel Besser, Oxford Kathleen Gilllespie Parth Narendran Update on screening efforts on type 1 diabetes 11:50 am12:10 pm Parth Narendran, Birmingham
Wed26 Diabetic Medicine symposium: Early onset type 2 diabetes in pregnancy and preconception 11:50 am12:50 pm Lomond Chair:Robert Lindsay, Glasgow Claire Meek, Leicester Nick Oliver, London Sharon Mackin, Glasgow Danielle Schoenaker, Southampton Sara White, London Uncharted territory: What can we learn about type 2 diabetes in pregnancy from Scottish data? 11:50 am12:05 pm Sharon Mackin, Glasgow Preconception care in type 2 diabetes: Evidence to practice 12:05 pm12:20 pm Danielle Schoenaker, Southampton Pregnancy care in type 2 diabetes: What is the current landscape and where are we heading? 12:20 pm12:30 pm Sara White, London Debate and the panel discussion to inform consensus statement 12:30 pm12:50 pm Robert Lindsay, Glasgow Claire Meek, Leicester Nick Oliver, London
Uncharted territory: What can we learn about type 2 diabetes in pregnancy from Scottish data? 11:50 am12:05 pm Sharon Mackin, Glasgow
Preconception care in type 2 diabetes: Evidence to practice 12:05 pm12:20 pm Danielle Schoenaker, Southampton
Pregnancy care in type 2 diabetes: What is the current landscape and where are we heading? 12:20 pm12:30 pm Sara White, London
Debate and the panel discussion to inform consensus statement 12:30 pm12:50 pm Robert Lindsay, Glasgow Claire Meek, Leicester Nick Oliver, London
Wed26 Preparing the UK for early detection and treatment of type 1 diabetes 11:50 am01:20 pm Hall 5 Chair:Kathleen Gillespie, Bristol Susan Wong, Cardiff Parth Narendran, Birmingham Rachel Besser, Oxford Colin Dayan, Cardiff Kimber Simmons, Colorado, United States Update on screening efforts on type 1 diabetes 11:50 am12:10 pm Parth Narendran, Birmingham Managing screen detected type 1 diabetes 12:10 pm12:30 pm Rachel Besser, Oxford Delaying the need for insulin 12:30 pm12:50 pm Colin Dayan, Cardiff Real-world US experience with teplizumab for type 1 diabetes prevention 12:50 pm1:10 pm Kimber Simmons, Colorado, United States Facilitated discussion 1:10 pm1:20 pm Parth Narendran, Birmingham Rachel Besser, Oxford Colin Dayan, Cardiff Kimber Simmons, Colorado, United States
Real-world US experience with teplizumab for type 1 diabetes prevention 12:50 pm1:10 pm Kimber Simmons, Colorado, United States
Facilitated discussion 1:10 pm1:20 pm Parth Narendran, Birmingham Rachel Besser, Oxford Colin Dayan, Cardiff Kimber Simmons, Colorado, United States
Wed26 Predicting and preventing diabetes related cardiometabolic diseases and complications: Reviews of current evidence, guidelines and recommendations for early detection and management of heart, liver and kidney disease 11:50 am01:20 pm Alsh Chair:Ahmad Moolla, London Ameet Bakhai, LondonGuru Aithal, Nottingham David Wheeler, London Cardiac co-morbidity in people living with diabetes: Review of evidence for screening for cardiac disease and the benefits of prompt intervention 11:50 am12:15 pm Ameet Bakhai, London Metabolic associated steatotic liver disease, a review of latest best practice and guidelines for screening and management in patients with diabetes 12:15 pm12:40 pm Guru Aithal, Nottingham Multidisciplinary and specialist care provision in diabetes and renal disease, the benefits of early intervention and judicious management 12:40 pm1:05 pm Guru Aithal, Nottingham Panel discussion on multidisciplinary working in diabetes care 1:05 pm1:20 pm Ameet Bakhai, LondonGuru Aithal, Nottingham David Wheeler, London
Cardiac co-morbidity in people living with diabetes: Review of evidence for screening for cardiac disease and the benefits of prompt intervention 11:50 am12:15 pm Ameet Bakhai, London
Metabolic associated steatotic liver disease, a review of latest best practice and guidelines for screening and management in patients with diabetes 12:15 pm12:40 pm Guru Aithal, Nottingham
Multidisciplinary and specialist care provision in diabetes and renal disease, the benefits of early intervention and judicious management 12:40 pm1:05 pm Guru Aithal, Nottingham
Panel discussion on multidisciplinary working in diabetes care 1:05 pm1:20 pm Ameet Bakhai, LondonGuru Aithal, Nottingham David Wheeler, London
Wed26 Neurodivergence and diabetes: What is it, who does it affect and how can i help? 11:50 am01:20 pm Dochart Chair:Rose Stewart, Wrexham Rose Stewart, Wrexham Vicky Mckechnie, London Jacqueline Allan, Norwich Opening comments 11:50 am11:55 am Rose Stewart, Wrexham Introduction to neurodivergence 11:55 am12:10 pm Vicky Mckechnie, London NHS approaches to neurodivergence 12:10 pm12:25 pm Rose Stewart, Wrexham When neurodivergence and diabetes meet 12:25 pm12:50 pm Jacqueline Allan, Norwich Clinical skills and resources for neuroaffirmative care in diabetes 12:50 pm1:10 pm Rose Stewart, Wrexham Panel questions 1:10 pm1:20 pm Rose Stewart, Wrexham Vicky Mckechnie, London Jacqueline Allan, Norwich
Clinical skills and resources for neuroaffirmative care in diabetes 12:50 pm1:10 pm Rose Stewart, Wrexham
Panel questions 1:10 pm1:20 pm Rose Stewart, Wrexham Vicky Mckechnie, London Jacqueline Allan, Norwich
Wed26 Technology, tools and innovation 11:50 am01:20 pm Carron Chair:Khor Benedicitine, Glasgow Adrian Heald, Manchester
Wed26 Diabetes UK Young People's Diabetes Service Award 01:30 pm02:00 pm Poster theatre (Exhibition Hall)
